KeyBank National Association
INO icon

KeyBank National Association’s Inovio Pharmaceuticals INO Stock Holding History

KeyBank National Association’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,909
Closed -$328K – 988
2018
Q3 		$328K Sell
4,909
-486
-9% -$27.1K ﹤0.01% 876
2018
Q2 		$254K Buy
5,395
+718
+15% +$39.6K ﹤0.01% 919
2018
Q1 		$264K Buy
4,677
+693
+17% +$37.5K ﹤0.01% 910
2017
Q4 		$197K Buy
3,984
+416
+12% +$25.8K ﹤0.01% 992
2017
Q3 		$271K Buy
3,568
+1,048
+42% +$78K ﹤0.01% 950
2017
Q2 		$237K Hold
2,520
– – ﹤0.01% 1002
2017
Q1 		$200K Hold
2,520
– – ﹤0.01% 1088
2016
Q4 		$210K Buy
2,520
+162
+7% +$14.6K ﹤0.01% 1073
2016
Q3 		$264K Buy
2,358
+175
+8% +$19.3K ﹤0.01% 1017
2016
Q2 		$242K Hold
2,183
– – ﹤0.01% 996
2016
Q1 		$228K Sell
2,183
-507
-19% -$39.1K ﹤0.01% 996
2015
Q4 		$217K Buy
2,690
+751
+39% +$59.8K ﹤0.01% 1038
2015
Q3 		$134K Hold
1,939
– – ﹤0.01% 1097
2015
Q2 		$190K Hold
1,939
– – ﹤0.01% 1149
2015
Q1 		$190K Buy
1,939
+424
+28% +$41.1K ﹤0.01% 1163
2014
Q4 		$167K Buy
+1,515
New +$185K ﹤0.01% 1173

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

KeyBank National Association's INO Position: Q4 2018 in Review

KeyBank National Association sold out of Inovio Pharmaceuticals (INO) in Q4 2018, closing a stake of 4,909 shares — an estimated $328K sold.

KeyBank National Association first reported a position in INO in Q4 2014 and held it in 16 quarters. The position peaked at $328K in Q3 2018. 125 funds tracked by Wall St. Rank hold INO as of Q4 2018.

  • KeyBank National Association reported no remaining Inovio Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • KeyBank National Association sold 4,909 Inovio Pharmaceuticals shares in Q4 2018, an estimated $328K.
  • KeyBank National Association first reported a position in Inovio Pharmaceuticals in Q4 2014 and held it in 16 quarters.
  • KeyBank National Association's Inovio Pharmaceuticals position peaked at $328K in Q3 2018.
  • 125 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2018.

Based on KeyBank National Association's 13F filing for Q4 2018, filed 30 Jan 2019.